Synjardy

Empagliflozin,

Metformin Hydrochloride

4.7 Moderate risk

Synjardy & Diabetic ketoacidosis

19.6%

of users reported Diabetic ketoacidosis

58.0%

also reported Hospitalization

51.2%

are women

Most common medical consequences

Hospitalization
58.0%
Severe reaction
35.8%
Life-threatening condition
6.2%

Have you experienced any negative side effects from this medication?

Synjardy: general information

Most common side effects (13)

Most commonly affected ages

40 - 49 years
8.6%
50 - 59 years
35.9%
60 - 69 years
38.2%
70 - 79 years
17.3%